The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada
Open accessAbstract
BACKGROUND: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000-2007 in the U.S. and Canada. METHODS: Participants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged ≥20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables. RESULTS: The crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000-2002 to 2006-2007. Men and women had comparable life expectancies in all periods except the last (2006-2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts <350 cells/mm(3). CONCLUSIONS: A 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population. Differences by sex, race, HIV transmission risk group, and CD4 count remain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Self-citationGuidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Social determinants of health inequalities
Marmot, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71146-6 · Cited by 5,086
Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
HIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
Self-citationHammer, S. M., Eron, J. J., Reiss, P., Schooley, R. T., Thompson, M. A., Walmsley, S., Cahn, P., Fischl, M. A., Gatell, J. M., Hirsch, M. S., et al. (2008) · JAMA · doi:10.1001/jama.300.5.555 · Cited by 1,026
Patel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., Holmberg, S. D., Brooks, J. T., & for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00005 · Cited by 942
Robins, J. M., & Finkelstein, D. M. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00779.x · Cited by 877
Montaner, J. S., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., Shannon, K., Harrigan, P. R., Hogg, R. S., Daly, P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60936-1 · Cited by 780 · cited 1×
“ART is effective in increasing the life span of HIV-positive individuals [2] and is associated with a reduction in new infections [4–6].”
BackgroundSelf-citation
Cited by
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
Trickey, A., May, M. T., Vehreschild, J.-J., Obel, N., Gill, M. J., Crane, H. M., Boesecke, C., Patterson, S., Grabar, S., Cazanave, C., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30066-8 · Cited by 1,082
Self-citationMarcus, J. L., Leyden, W. A., Alexeeff, S. E., Anderson, A. N., Hechter, R. C., Hu, H., Lam, J. O., Towner, W. J., Yuan, Q., Horberg, M. A., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.7954 · Cited by 642
Self-citationTrickey, A., Sabin, C. A., Burkholder, G., Crane, H., d'Arminio Monforte, A., Egger, M., Gill, M. J., Grabar, S., Guest, J. L., Jarrin, I., et al. (2023) · The Lancet HIV · doi:10.1016/s2352-3018(23)00028-0 · Cited by 529
Self-citationUse Your Words Carefully: What Is a Chronic Disease?
Bernell, S., & Howard, S. W. (2016) · Frontiers in Public Health · doi:10.3389/fpubh.2016.00159 · Cited by 489
Kim, E. S., Bruinooge, S. S., Roberts, S., Ison, G., Lin, N. U., Gore, L., Uldrick, T. S., Lichtman, S. M., Roach, N., Beaver, J. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7916 · Cited by 485
Selenium, Selenoproteins and Viral Infection
Guillin, O., Vindry, C., Ohlmann, T., & Chavatte, L. (2019) · Nutrients · doi:10.3390/nu11092101 · Cited by 443
Marcus, J. L., Chao, C. R., Leyden, W. A., Xu, L., Quesenberry, C. P., Klein, D. B., Towner, W. J., Horberg, M. A., & Silverberg, M. J. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001014 · Cited by 439
“Our findings demonstrate that ART initiation at high CD4 counts is associated with a reduced gap in life expectancy for HIV patients, consistent with previous studies identifying timely ART initiation as a strong predictor of survival.(3,4,6,45) We found that the survival gap compared with HIV-uninfected subjects was…”
BackgroundResultSelf-citationTeeraananchai, S., Kerr, S., Amin, J., Ruxrungtham, K., & Law, M. (2017) · HIV Medicine · doi:10.1111/hiv.12421 · Cited by 433
Wandeler, G., Johnson, L. F., & Egger, M. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000298 · Cited by 399
Oxidative Stress during HIV Infection: Mechanisms and Consequences
Ivanov, A. V., Valuev-Elliston, V. T., Ivanova, O. N., Kochetkov, S. N., Starodubova, E. S., Bartosch, B., & Isaguliants, M. G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8910396 · Cited by 365
Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis
Wang, Y., Liu, M., Lu, Q., Farrell, M., Lappin, J. M., Shi, J., Lu, L., & Bao, Y. (2020) · Neurology · doi:10.1212/wnl.0000000000010752 · Cited by 348
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study
Silverberg, M. J., Lau, B., Achenbach, C. J., Jing, Y., Althoff, K. N., D'Souza, G., Engels, E. A., Hessol, N. A., Brooks, J. T., Burchell, A. N., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2768 · Cited by 328
Self-citationWing, E. J. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.10.004 · Cited by 287
Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data
Byrd, K. K., Hou, J. G., Hazen, R., Kirkham, H., Suzuki, S., Clay, P. G., Bush, T., Camp, N. M., Weidle, P. J., Delpino, A., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002142 · Cited by 285
Althoff, K. N., McGinnis, K. A., Wyatt, C. M., Freiberg, M. S., Gilbert, C., Oursler, K. K., Rimland, D., Rodriguez-Barradas, M. C., Dubrow, R., Park, L. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu869 · Cited by 276
Self-citationfor the Canadian Observation Cohort (CANOC) Collaboration, Tanner, Z., Lachowsky, N., Ding, E., Samji, H., Hull, M., Cescon, A., Patterson, S., Chia, J., Leslie, A., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1926-z · Cited by 270
Self-citationPatel, P., Rose, C. E., Collins, P. Y., Nuche-Berenguer, B., Sahasrabuddhe, V. V., Peprah, E., Vorkoper, S., Pastakia, S. D., Rausch, D., & Levitt, N. S. (2018) · AIDS · doi:10.1097/qad.0000000000001888 · Cited by 270
Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection
Hunt, P. W., Lee, S. A., & Siedner, M. J. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw275 · Cited by 266
Prevalence of Immunosuppression Among US Adults, 2013
Harpaz, R., Dahl, R. M., & Dooling, K. L. (2016) · JAMA · doi:10.1001/jama.2016.16477 · Cited by 266
Thompson, M. A., Horberg, M. A., Agwu, A. L., Colasanti, J. A., Jain, M. K., Short, W. R., Singh, T., & Aberg, J. A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1391 · Cited by 256
Rechlin, R. K., Splinter, T. F. L., Hodges, T. E., Albert, A. Y., & Galea, L. A. M. (2022) · Nature Communications · doi:10.1038/s41467-022-29903-3 · Cited by 218
Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
Kirtane, A. R., Abouzid, O., Minahan, D., Bensel, T., Hill, A. L., Selinger, C., Bershteyn, A., Craig, M., Mo, S. S., Mazdiyasni, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02294-6 · Cited by 227
Freeman, R., Gwadz, M. V., Silverman, E., Kutnick, A., Leonard, N. R., Ritchie, A. S., Reed, J., & Martinez, B. Y. (2017) · International Journal for Equity in Health · doi:10.1186/s12939-017-0549-3 · Cited by 184
Reddy, K. P., Parker, R. A., Losina, E., Baggett, T. P., Paltiel, A. D., Rigotti, N. A., Weinstein, M. C., Freedberg, K. A., & Walensky, R. P. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw430 · Cited by 135
Towards achieving the 90–90–90 HIV targets: results from the south African 2017 national HIV survey
Marinda, E., Simbayi, L., Zuma, K., Zungu, N., Moyo, S., Kondlo, L., Jooste, S., Nadol, P., Igumbor, E., Dietrich, C., et al. (2020) · BMC Public Health · doi:10.1186/s12889-020-09457-z · Cited by 131
Illuminating circuitry relevant to psychiatric disorders with optogenetics
Steinberg, E. E., Christoffel, D. J., Deisseroth, K., & Malenka, R. C. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.08.004 · Cited by 92
“Once thought to be facing a death sentence, many HIVinfected patients now look forward to life expectancies on par with the general population [1].”
BackgroundLosina, E., Hyle, E. P., Borre, E. D., Linas, B. P., Sax, P. E., Weinstein, M. C., Rusu, C., Ciaranello, A. L., Walensky, R. P., & Freedberg, K. A. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix547 · Cited by 62
The feasibility of lung transplantation in HIV-seropositive patients
Kern, R. M., Seethamraju, H., Blanc, P. D., Sinha, N., Loebe, M., Golden, J., Kukreja, J., Scheinin, S., Hays, S., Kleinhenz, M. E., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201402-083oc · Cited by 58
Samad, F., Harris, M., Puskas, C. M., Ye, M., Chia, J., Chacko, S., Bondy, G. P., Lima, V. D., Montaner, J. S., & Guillemi, S. A. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000457 · Cited by 53
Velichkovska, M., Surnar, B., Nair, M., Dhar, S., & Toborek, M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01014 · Cited by 49
Substance use and the HIV care continuum: important advances
Korthuis, P. T., & Edelman, E. J. (2018) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0114-4 · Cited by 37
“While antiretroviral therapy has dramatically improved the life expectancy for people living with HIV, important disparities remain among people with substance use that threaten individual and public health [2].”
BackgroundSelf-citationmHealth Interventions to Promote Anti-Retroviral Adherence in HIV: Narrative Review
Lee, S. B., & Valerius, J. (2020) · JMIR mHealth and uHealth · doi:10.2196/14739 · Cited by 34
Resistance to HIV integrase strand transfer inhibitors: in vitro findings and clinical consequences
Grobler, J. A., & Hazuda, D. J. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.07.006 · Cited by 30
Past, Present, and Future Drug Delivery Systems for Antiretrovirals
Kirtane, A. R., Langer, R., & Traverso, G. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.09.015 · Cited by 28
Lubetkin, E. I., Guidry, J. A., Webb, A., Ocampo, A., & Burkhalter, J. E. (2018) · AIDS Care · doi:10.1080/09540121.2017.1363366 · Cited by 8
“(PLWHA) has significantly improved (Samji et al., 2013; Siddiqi, Hall, Hu, & Song, 2016), the prevalence of certain risk behaviors and co-morbid conditions”
Background
Metadata
- Authors
- Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., Burchell, A. N., Cohen, M., Gebo, K. A., Gill, M. J., Justice, A., Kirk, G., Klein, M. B., Korthuis, P. T., Martin, J., Napravnik, S., Rourke, S. B., Sterling, T. R., Silverberg, M. J., Deeks, S., Jacobson, L. P., Bosch, R. J., Kitahata, M. M., Goedert, J. J., Moore, R., Gange, S. J., & for The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-12-18
- Volume
- 8
- Issue
- 12
- Pages
- e81355
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2115719856
- Cited by
- 1,417
- References
- 31
- FWCI
- 73.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.